Nano Dimension Divests AME Line in Strategic Shift to Inspira's Quantum Bet

WALTHAM, MA – April 06, 2026 – In a significant strategic realignment, Nano Dimension Ltd. today announced the sale of its additively manufactured electronics (AME) and previously discontinued Fabrica product lines. The buyer, in a surprising twist, is medical device firm Inspira Technologies OXY B.H.N. Ltd., which is acquiring the technology as the cornerstone of a radical pivot into the quantum computing sector.

The deal, valued at up to $12.5 million, involves a $2.0 million upfront cash payment to Nano Dimension, with an additional $10.5 million in deferred payments contingent on the product lines' performance over the next year under Inspira's new ownership. For Nano Dimension, the divestment marks a critical step in a broader effort to streamline its operations and bolster its financial standing.

A Strategic Reset for Nano Dimension

This sale is the most tangible outcome yet of Nano Dimension's ongoing “strategic alternatives review process,” an initiative designed to maximize shareholder value. The company projects the transaction will reduce its annualized cash burn by a substantial $10 million, providing a significant boost to its liquidity and financial flexibility. Following a comprehensive review of its assets, Nano Dimension's management and board concluded that the AME and Fabrica divisions were no longer aligned with its core forward-looking priorities.

This move toward consolidation and operational efficiency represents a stark departure from the company’s recent history, which was characterized by aggressive, though ultimately unsuccessful, M&A ambitions. Notably, Nano Dimension spent much of 2022 and 2023 in a high-profile, unsolicited pursuit to acquire competitor Stratasys Ltd., a campaign that ended after Stratasys opted for a different merger. The current divestment signals a strategic pivot inward, focusing on strengthening the balance sheet and concentrating resources on its primary digital manufacturing technologies for the defense, aerospace, and automotive industries.

David Stehlin, Chief Executive Officer of Nano Dimension, commented on the move in the company's official press release. “Today’s announcement marks the first of a series of steps to maximize shareholder value and builds on the cost reduction actions initiated in the third quarter of 2025,” he stated. “The sale of the AME and Fabrica product lines will lower our operating costs and cash burn while reinforcing financial flexibility, and the deferred consideration structure allows us to participate in potential upside as the product lines perform under Inspira’s ownership.”

The company has confirmed it will continue to evaluate further strategic alternatives and plans to update its 2026 financial guidance during its upcoming first-quarter earnings call.

Inspira's Audacious Leap into Quantum Computing

While the sale is a move toward consolidation for Nano Dimension, it represents a high-stakes gamble for the buyer. Inspira Technologies, a small-cap medical device company, has been facing significant financial headwinds. With a market capitalization of around $21 million, the company reported a net loss of over $13 million in its last fiscal year and has an Altman Z-Score indicating a high risk of financial distress. Its core business has been developing respiratory support technology as an alternative to invasive mechanical ventilation.

However, the acquisition of the AME platform is not intended to bolster its medical device portfolio. Instead, it is the centerpiece of a complete corporate reinvention. Inspira has announced its intention to rebrand as Qtrex Ltd. and pivot entirely into the quantum computing industry. This audacious move is being driven by Inspira's CEO, Dagi Ben-Noon, who brings a unique and intimate knowledge to the transaction—he is a co-founder of Nano Dimension and was one of the original developers of the very AME technology he is now acquiring.

Inspira's leadership believes the AME platform, which Nano Dimension invested over $200 million to develop, holds the key to solving critical hardware challenges that currently limit the scalability and fidelity of quantum computers. Specifically, the technology's ability to 3D print complex, multi-material electronic layers with microscopic precision could be used to address persistent issues with interconnect density, thermal loading, and electromagnetic interference within the cryogenic dilution refrigerators essential for quantum systems. If successful, this could represent a significant breakthrough for quantum hardware.

A Tale of Two Divergent Strategies

The transaction creates a fascinating case study in corporate strategy and the shifting valuation of technology. An asset deemed non-core by one company has become the cornerstone of another's high-risk, high-reward future. For Nano Dimension, shedding the AME line is a pragmatic decision to focus on profitability and stability within its established industrial markets. The move is designed to please investors by improving financial metrics and clarifying the company's strategic focus.

For Inspira, the acquisition is a speculative bet on a nascent, multi-billion-dollar market. By leveraging technology developed by a larger player, it hopes to leapfrog into a highly specialized and potentially lucrative field. The market has shown initial optimism for this bold strategy, with Inspira's stock (IINN) jumping over 20% in the week following the announcement, as investors weighed the potential rewards against the considerable risks.

The fate of the AME technology now shifts from a supporting role in a broad digital manufacturing portfolio to a starring role in the ambitious and uncertain world of quantum computing. While Nano Dimension refines its existing business, the industry will be watching to see if Inspira's audacious bet can transform a struggling medical device firm into a key player in the next generation of high-performance computing.